Quick Take: In Q3 2020, Compass (CMPS) completed a $146.6 million IPO… continued progress with phase IIb psilocybin therapy clinical trial… strengthened board and leadership team… and launched Drug Discovery Center The net loss for the three months ended 30 September 2020 was $16.7 million, or $1.30 loss per share London, UK, Nov. 12, 2020…